SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-17-003764
Filing Date
2017-04-18
Accepted
2017-04-18 16:02:38
Documents
5
Effectiveness Date
2017-04-18

Document Format Files

Seq Description Document Type Size
1 DEFA14A adms123116proxyadditionalm.htm DEFA14A 22167
2 noticepg1.jpg GRAPHIC 83381
3 noticepg2.jpg GRAPHIC 140246
4 noticepg3.jpg GRAPHIC 39866
5 noticepg4.jpg GRAPHIC 20110
  Complete submission text file 0001628280-17-003764.txt   392631
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36399 | Film No.: 17767050
SIC: 2834 Pharmaceutical Preparations